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EDITORIAL  
Respiratory influences on oxygen transport and exercise 
performance in health and disease  
Transport of O2 from inspired air to the mitochondria in contracting skeletal muscle requires 
a coordinated interaction of several physiological systems. The respiratory system is typically 
considered to be responsible for the first two steps in O2 transport – namely, the bulk 
movement of O2 in atmospheric air to alveoli (ventilation) and the transfer of O2 from 
alveolar gas to capillary blood in the lungs (diffusion). However, it is increasingly 
appreciated that the respiratory system may impact on systemic O2 transport via direct, 
mechanical effects on cardiac output and indirect, reflex effects on muscle blood flow and its 
regional distribution. Insufficient O2 transport to working muscles increases the reliance on 
anaerobic energy systems, thereby facilitating the accumulation of metabolites. In turn, the 
development of contractile dysfunction (peripheral fatigue) is accelerated, with a 
corresponding increase in the activation of metaboreceptor afferents and a reduction in the 
neural drive to locomotor muscles (central fatigue). These respiratory influences on O2 
transport and exercise performance may be relatively minor in healthy individuals exercising 
at sea-level, but are likely to gain in relative importance as fitness level rises. Respiratory 
influences are also likely to gain in importance, even at submaximal exercise intensities, in 
healthy individuals in the hypoxia of high altitude and in a significant number of patients 
with cardiorespiratory disease.  
In this issue of Experimental Physiology, we present reports from a symposium entitled 
‘Respiratory influences on oxygen transport and exercise performance in health and disease’ 
that was held on 10 July 2019 at the annual meeting of The Physiological Society in 
Aberdeen, UK. The reports highlight recent work pertaining to the role of the respiratory 
system in limiting O2 transport and how these respiratory influences might compromise 
exercise performance in healthy individuals and in patients with chronic heart and/or lung 
disease.  
In their report, Sheel, Taylor, and Katayama (2020) emphasise recent findings in healthy 
humans that show a significant influence of sympathetic vasoconstrictor activity, mediated by 
both respiratory and locomotor muscle metaboreceptors during intense endurance exercise, 
on the constraint of blood flow and O2 transport to both sets of muscles. Experimentally 
increasing the work of breathing was found to elicit reductions in blood flow to inactive and 
active limb muscles during submaximal exercise, but only if the work of breathing was of a 
sufficient magnitude. Reducing the work of breathing by using a mechanical ventilator during 
intense exercise was found to increase blood flow to inspiratory muscles and to decrease 
blood flow to active limb muscles. Together, these findings support the concept of a 
significant influence of respiratory muscle work on the distribution of blood flow to both 
respiratory and locomotor muscles. More recently, reducing the normally occurring work of 
breathing during exercise was shown to decrease sympathetic nerve activity to non-involved 
muscles. This latter finding lends support to the notion of a ‘respiratory muscle 
metaboreflex’, whereby high respiratory muscle work increases metaboreceptor afferent 
activity, which in turn increases sympathetic outflow, eliciting a redistribution of blood flow.  
In endurance-trained athletes capable of working at high cardiac outputs, excessive rises in 
pulmonary artery and capillary pressures and a limited pulmonary vascular reserve appear to 
place a disproportionate load on the right heart. These excessive increases in pulmonary 
vascular pressures may reduce O2 transport via reductions in stroke volume and impairments 
in pulmonary gas exchange. Increases in pulmonary vascular pressure are also likely to be 
important in older adults and especially in patients with cardiovascular disease. In their 
report, Taylor, Shapiro, and Johnson (2020) discuss the impact of pulmonary hypertension on 
the pulmonary haemodynamic response to exercise in patients with heart failure. Emphasis is 
placed on the causes of exercise limitation in two distinct subsets of pulmonary hypertension: 
(1) isolated postcapillary pulmonary hypertension; and (2) combined pre- and postcapillary 
pulmonary hypertension. The authors provide evidence that pulmonary hypertension 
contributes to exercise limitation in heart failure through a substantial increase in right 
ventricular afterload that restricts right ventricular contractile reserve and forward flow of 
blood from the right ventricle to the pulmonary vasculature and systemic circulation.  
Cystic fibrosis is an autosomal recessive condition caused by mutations to the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene. CFTR protein is expressed in multiple 
organs and, thus, this complex condition could pose significant limitations to central and 
localised O2 delivery as well as the ability to effectively extract and utilise O2 at the myocyte 
level, even when pulmonary function is preserved. Saynor, Gruet, Rodriguez-Miguelez, and 
Harris (2020) review the central and peripheral contributors of cystic fibrosis 
pathophysiology that modulate the dynamic balance between O2 delivery and utilisation 
during exercise. The authors emphasise recent evidence showing that, at the mild end of the 
disease spectrum and at low intensities of exercise, the human body has the ability  
to physiologically compensate for some degree of dysfunction in an effort to maintain the 
metabolic demands of low-intensity exercise. With more severe dysfunction and more intense 
exercise, however, a pharmacological ‘helping hand’ may be needed to improve exercise 
performance.  
In contrast to most untrained healthy individuals, the respiratory system in patients with 
chronic obstructive pulmonary disease (COPD) may present significant challenges to 
systemic O2 transport and exercise performance. In their report, Vogiatzis, Louvaris, and 
Wagner (2020) discuss blood flow regulation during exercise in health and COPD. Using an 
indicator-dilution method, the authors have shown that blood flow to the intercostal region 
trends toward, or even falls below, resting values during intense exercise and that these 
dramatic reductions in flow are even more marked in COPD versus health. The authors 
attribute the apparent reductions in intercostal blood flow during exercise to mechanical 
compression of vessels within the muscle or to redistribution of blood flow within the 
respiratory muscles. Further insight into the priority of blood flow distribution during 
exercise in humans will require advances in techniques for the quantification of blood flow to 
diaphragm muscle.  
The symposium reports that feature in this issue of Experimental Physiology provide 
important new insights into how the respiratory system may influence O2 transport and 
exercise performance in health and disease. The reports have much to offer by way of 
informing our understanding of the limitations to human performance and the development of 
effective interventions.  
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